日本版的埃索美拉唑好不好

(Nexium) tablets should be swallowed whole with liquid and should not be chewed or crushed. For patients with dysphagia, dissolve the tablets in half a cup of non-carbonated water (other liquids should not be used as the enteric coating may be dissolved), stir until the tablets are completely disintegrated, take immediately or within 30 minutes, rinse with half a cup of water and drink. Pellets should never be chewed or crushed. For patients who cannot swallow, esomeprazole (Nexium) tablets may be dissolved in carbonate-free water and administered through a gastric tube. It is important to carefully check the fit of the syringe and gastric tube chosen. Today let’s learn more about the Japanese version of esomeprazole, shall we?

In a clinical comparative study of esomeprazole (Nexium) and omeprazole in the treatment of reflux esophagitis, the total effective rate of esomeprazole was 97.18%, which was significantly higher than 84.51% of omeprazole, and there was no significant difference in the incidence of adverse reactions. Chen Caiming conducted a cost-effectiveness analysis of omeprazole and esomeprazole in the treatment of duodenal ulcer. The recovery rate of the esomeprazole group was 92.6%, which was higher than that of omeprazole, 78.6%. The results proved that esomeprazole has cost and effectiveness advantages.

Clinical trial results show that esomeprazole (Nexium) is effective in treating pediatric patients. GERD is characterized by abnormal closure of the sphincter, causing gastric acid to reflux into the esophagus. Children and adults suffering from the disease often experience heartburn, regurgitation and stomach discomfort. If left untreated, acid reflux can lead to potentially damaging inflammation of the esophagus, also known as erosive esophagitis. 

The active ingredient of Esomeprazole (Nexium) Magnesium Enteric-Coated Tablets is esomeprazole magnesium. Esomeprazole is the S-isomer of omeprazole. It reduces gastric acid secretion through a specific targeting mechanism and is a specific inhibitor of proton pumps in parietal cells.

Esomeprazole (Nexium) has been marketed in many countries. In 2000, the oral formulation of esomeprazole (Nexium) was first launched in Sweden. In 2001, it was approved by the FDA to be marketed in the United States under the trade name esomeprazole. In 2003, esomeprazole sodium for injection developed by AstraZeneca was first launched in Sweden and was approved for marketing in the United States in 2005. For more information about esomeprazole, please consult Medical Companion Travel.

The above is the content of (Nexium) effect, I hope it can help you!

Recommended related hot articles: /newsDetail/71977.html